News & Events
Updated Clinical Data from Numerous Studies of AirXpanders' AeroForm
14 / 10 / 2014
Clinical data consistently show that patients undergoing breast reconstruction after a mastectomy can complete expansion significantly faster with AeroForm™ expanders than traditional saline expanders Separate analyses show that it is safe to fly with AeroForm implanted and patients can undergo radiation therapy for residual breast cancer while completing the expansion process
Neurovance Appoints Brigitte Robertson, MD, Vice President, Clinical Development
05 / 08 / 2014
Dr. Robertson Brings ADHD Expertise to Advance Neurovance’s Centanafadine SR Program Neurovance’s Lead Product EB-1020 SR Granted Non-Proprietary Name; Now Called Centanafadine SR
Celladon Corporation Secures $25 Million Credit Facility from Hercules Growth Capital
01 / 08 / 2014
Celladon Corporation Announces In-License of Stem Cell Factor Development Program
21 / 07 / 2014
License Brings Novel Gene Therapy Approach for in situ Targeting of Multi-Potent Stem Cells for the Heart
Spinifex Pharmaceuticals Appoints Neuroscience Expert Dr Ronald Marcus as Chief Medical Officer
03 / 06 / 2014
Celladon Corporation Appoints Paul Cleveland as President and Chief Financial Officer
03 / 06 / 2014
Spinifex Pharmaceuticals Strengthens Scientific Advisory Board (SAB) with Experts in Chronic Pain
27 / 05 / 2014
Sunshine Heart Announces Presentations at the Annual Meeting of the Heart Failure Association
14 / 05 / 2014
PLC Systems Proposes Series of Business Transactions Designed to Preserve Value for Shareholders
14 / 05 / 2014
FDA Approves Teva SYNRIBO® (Omacetaxine Mepesuccinate) for Injection for Home Administration
07 / 05 / 2014
New Labeling will Offer People Living with Chronic Myeloid Leukemia (CML) More Treatment Flexibility
Celladon Receives Breakthrough Therapy Designation From FDA for MYDICAR(R)
10 / 04 / 2014
MYDICAR is First Gene Therapy Reported to Receive Breakthrough Designation From FDA's Center for Biologics Evaluation and Research (CBER)